This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mitsui Chemicals, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Harutake Yamazaki: Inventor in Biotechnology
Introduction
Harutake Yamazaki is an inventor associated with Mitsui Chemicals, Inc. His listed location is Niigata, Japan, and his patent work concerns an engineered enzyme and its use in producing a chemical compound.
Latest Patents
Yamazaki is credited with 1 patent, titled “Mutant Type 2-Deoxy-scyllo-Inosose Synthase.” The patent describes a polypeptide based on the amino acid sequence of SEQ ID NO: 1, or a similar sequence, with at least one specified substitution at one or more of the 14th, 37th, 209th, 293rd, or 319th amino acid residues. It also covers encoding polynucleotides, expression cassettes, vectors, and transformants, as well as methods for producing the polypeptide and 2-deoxy-scyllo-inosose.
Career Highlights
The patent reflects work in enzyme engineering and biotechnology, focusing on modifying 2-deoxy-scyllo-inosose synthase and applying the resulting polypeptide in production methods. The available information identifies Yamazaki’s company affiliation as Mitsui Chemicals, Inc.
Collaborations
Hiroaki Takaku and Daisuke Miyazawa are listed as Yamazaki’s coworkers.
Conclusion
Harutake Yamazaki’s recorded patent contribution centers on an engineered synthase and related tools and methods for producing 2-deoxy-scyllo-inosose.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile